UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON

Ophthalmology (Rochester, Minn.), 2013-11, Vol.120 (11), p.2292-2299

2013

Volltextzugriff (PDF)

Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study

Ophthalmology (Rochester, Minn.), 2011-08, Vol.118 (8), p.1594-1602

2011

Volltextzugriff (PDF)

Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: the SEVEN-UP Study

American journal of ophthalmology, 2015-05, Vol.159 (5), p.915-924.e2

2015

Volltextzugriff (PDF)

Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)

Ophthalmology (Rochester, Minn.), 2016-06, Vol.123 (6), p.1269-1277

2016

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Promotes Progressive Retinal Nonperfusion in Patients with Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2013-04, Vol.120 (4), p.795-802

2013

Volltextzugriff (PDF)

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2007-02, Vol.114 (2), p.246-252

2007

Volltextzugriff (PDF)

Predictive Value in Retinal Vein Occlusions of Early Versus Late or Incomplete Ranibizumab Response Defined by Optical Coherence Tomography

Ophthalmology (Rochester, Minn.), 2013-05, Vol.120 (5), p.1057-1063

2013

Volltextzugriff (PDF)

Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease

Molecular therapy. Nucleic acids, 2019-09, Vol.17, p.819-828

2019

Volltextzugriff (PDF)

Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)

Ophthalmology (Rochester, Minn.), 2013-11, Vol.120 (11), p.2292-2299

2013

Volltextzugriff (PDF)

Rhegmatogenous retinal detachment masquerading as exudative panuveitis with intense anterior chamber inflammatory reaction

American journal of ophthalmology case reports, 2020-06, Vol.18, p.100618-100618, Article 100618

2020

Volltextzugriff (PDF)

Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab

British journal of ophthalmology, 2024-09, Vol.108 (9), p.1216-1225

2024

Volltextzugriff (PDF)

Neuroprotective Effect of Intravitreal Triamcinolone Acetonide against Photoreceptor Apoptosis in a Rabbit Model of Subretinal Hemorrhage

Investigative ophthalmology & visual science, 2008-09, Vol.49 (9), p.4071-4077

2008

Volltextzugriff (PDF)

Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma

Investigative ophthalmology & visual science, 2016-08, Vol.57 (10), p.4341-4346

2016

Volltextzugriff (PDF)

Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films

Journal of ocular pharmacology and therapeutics, 2013-03, Vol.29 (2), p.249-257

2013

Volltextzugriff (PDF)

Glass intraocular foreign body removal with a nitinol stone basket

American journal of ophthalmology case reports, 2019-12, Vol.16, p.100541, Article 100541

2019

Volltextzugriff (PDF)

Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study

Eye (London), 2024-04, Vol.38 (6), p.1149-1154

2024

Volltextzugriff (PDF)

Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients

Eye (London), 2024-04, Vol.38 (6), p.1140-1148

2024

Volltextzugriff (PDF)

Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent

Journal of controlled release, 2018-01, Vol.269, p.45-51

2018

Volltextzugriff (PDF)

Macular Atrophy Incidence, Progression, and Visual Acuity Effects in 5-Year Treatment of Neovascular Age-Related Macular Degeneration

Ophthalmic surgery, lasers & imaging retina, 2022-10, Vol.53 (10), p.546-552

2022

Volltextzugriff (PDF)

Subretinal hyperreflective material in regions of atrophy and fibrosis in eyes with neovascular age-related macular degeneration

Canadian journal of ophthalmology, 2024-05

2024

Volltextzugriff (PDF)

Risk factors for retinal detachment following cataract surgery

Current opinion in ophthalmology, 2012-01, Vol.23 (1), p.7-11

2012

Volltextzugriff (PDF)

Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device

Journal of ocular pharmacology and therapeutics, 2019-03, Vol.35 (2), p.124-131

2019

Volltextzugriff (PDF)

In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device

Investigative ophthalmology & visual science, 2015-11, Vol.56 (12), p.7331-7337

2015

Volltextzugriff (PDF)

Spontaneous resolution of a traumatic cataract caused by an intralenticular foreign body

Journal of cataract and refractive surgery, 2008-06, Vol.34 (6), p.1033-1035

2008

Volltextzugriff (PDF)

Injectable Devices for Delivery of Liquid or Solid Protein Formulations

ACS Materials Au, 2023-05, Vol.3 (3), p.255-264

2023

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(64)
Berichte
(1)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Ophthalmology
(40)
Humans
(30)
Female
(19)
Male
(18)
Animals
(12)
Fluorescein Angiography
(12)
Biological And Medical Sciences
(11)
Follow-Up Studies
(11)
Medical Sciences
(11)
Ranibizumab
(11)
Aged
(10)
Angiogenesis Inhibitors - Therapeutic Use
(10)
Treatment Outcome
(10)
Middle Aged
(9)
Vascular Endothelial Growth Factor
(9)
Vascular Endothelial Growth Factor A - Antagonists & Inhibitors
(9)
Visual Acuity - Physiology
(9)
Macular Degeneration
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON

Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study

Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: the SEVEN-UP Study

Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)

Vascular Endothelial Growth Factor Promotes Progressive Retinal Nonperfusion in Patients with Retinal Vein Occlusion

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

Predictive Value in Retinal Vein Occlusions of Early Versus Late or Incomplete Ranibizumab Response Defined by Optical Coherence Tomography

Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease

Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)

Rhegmatogenous retinal detachment masquerading as exudative panuveitis with intense anterior chamber inflammatory reaction

Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab

Neuroprotective Effect of Intravitreal Triamcinolone Acetonide against Photoreceptor Apoptosis in a Rabbit Model of Subretinal Hemorrhage

Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma

Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films

Glass intraocular foreign body removal with a nitinol stone basket

Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study

Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients

Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent

Macular Atrophy Incidence, Progression, and Visual Acuity Effects in 5-Year Treatment of Neovascular Age-Related Macular Degeneration

Subretinal hyperreflective material in regions of atrophy and fibrosis in eyes with neovascular age-related macular degeneration

Risk factors for retinal detachment following cataract surgery

Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device

In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device

Spontaneous resolution of a traumatic cataract caused by an intralenticular foreign body

Injectable Devices for Delivery of Liquid or Solid Protein Formulations

Suchergebnisse filtern